Eastgate Biotech Company Description
Eastgate Biotech Corp., produces and distributes nutraceuticals that are based on natural therapies and absorbed naturally by the body.
The company is developing pharmaceutical products, such as Lorazepam spray for acute seizures; and EGP-1214, intraoral (sublingual) insulin tablet for diabetes and metabolic syndrome.
It is also developing natural healing medication and other products, including E-drops NANO, a plant essential oil for urinary and vaginal tract infections; Essential, a Vitamin D3, to improve the body’s digestive, cardiovascular, and immune systems; GluCora to lower daily intake of insulin; VCleanzz, an antibacterial wash for fruits and vegetables; Cleanezze, a natural hand sanitizer; and Warts X, a natural herbal product to treats warts.
The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014.
Eastgate Biotech Corp. was incorporated in 1999 and is based in Toronto, Canada.
| Country | United States |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 3 |
| CEO | Rosella Perri |
Contact Details
Address: 65 Harbour Square Toronto, ON M5J 2L4 Canada | |
| Phone | 647-692-0652 |
| Website | EastGateBiotech.com |
Stock Details
| Ticker Symbol | ETBI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US2772531008 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Rosella C. Perri | Chief Executive Officer, Secretary, Treasurer and Director |
| William D. Abajian | Vice Chairman, President and Chief Operating Officer |
| Dr. Joseph Schwarz Ph.D. | Chief Scientific Officer |